Ruobin Lin

3PUBLICATIONS
30CO-AUTHORS
Medical devicesCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 27, 2025
Desmocollin 2 is a dominant entry receptor for Epstein-Barr virus infection of epithelial cells.

Hua Zhang, Yu-Chun Li, De Pang

|Jul 24, 2025
Cadonilimab (a PD-1/CTLA-4 Bispecific Antibody) plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase II Clinical Trial.

Fei Cao, Yan Li, Qi Fang

|Jun 18, 2025
R9AP is a common receptor for EBV infection in epithelial cells and B cells.

Yan Li, Hua Zhang, Cong Sun

Pageof 1

Frequent Collaborators

2 joint publications

Cong Sun

2 joint publications

Chu Xie

2 joint publications

Mu-Sheng Zeng

2 joint publications

Qian Zhong